2023-08-07 16:19:54 ET
- ICU Medical press release ( NASDAQ: ICUI ): Q2 Non-GAAP EPS of $1.88 beats by $0.28 .
- Revenue of $549.3M (-2.1% Y/Y) misses by $13.6M .
- Fiscal Year 2023 GuidanceFor Fiscal Year 2023 the Company estimates GAAP net loss to be in the range of $(59) to $(38) and GAAP diluted loss per share estimated to be in the range of $(2.42) to $(1.57).
- The Company narrowed the estimates of the range of its full year 2023 guidance of adjusted EBITDA from a range of $375 million to $425 million to a range of $375 million to $405 million and adjusted diluted earnings per share from a range of $5.75 to $7.25 to a range of $6.00 to $6.85.
For further details see:
ICU Medical Non-GAAP EPS of $1.88 beats by $0.28, revenue of $549.3M misses by $13.6M